Product Name	Melanotan 1-10mg
Purity	99%
Other Names	Melanotan1
CAS No.	75921-69-6
M.F.	C54H75N15O9
MW	1024.3 g/mol
Appearance	Freeze-dried powder,White powder White to off-white crystalline powder, easily soluble in water
Density	1.43
Storage Temperature	Store in a dry, cool, and light-protected place
Solubility	Soluble in water, saline, or buffered solutions

Melanotan-1 (MT-1) is a synthetic peptide analog of α-MSH (alpha-melanocyte-stimulating hormone), primarily used for:

Skin tanning (stimulates melanin production)

FDA-approved as Scenesse® for erythropoietic protoporphyria (EPP) (a rare light-sensitivity disorder)

More stable & longer-lasting than Melanotan-2 (MT-2), with fewer side effects

A 10mg vial is commonly used for clinical, research, or personal tanning protocols.

Feature	Melanotan-1 (MT-1)	Melanotan-2 (MT-2)
Tanning Efficiency	Slower but longer-lasting	Faster but fades quicker
Side Effects	Mild (less nausea, flushing)	More severe (nausea, libido effects)
FDA Approval	Yes (Scenesse® for EPP)	No
Libido Impact	Minimal	Strong (MC4R activation)
Dosing Frequency	1-2x/week	3-5x/week

Loading Phase (First 2-3 Weeks)

Start with 0.5mg (500mcg) every other day

Gradually increase to 1mg/day if tolerated

UV exposure required (sunlight or tanning bed, 2-3x/week)

Maintenance Phase

1mg 2x/week (maintains tan without continuous dosing)

EPP Treatment (Scenesse® Protocol)

FDA-approved dose: 16mg implant every 2 months

Not the same as 10mg vials (Scenesse® is a controlled-release implant)

Add 2mL bacteriostatic water → 5mg/mL concentration

Dosing Examples:

0.5mg dose = 10 units on insulin syringe (0.1mL)

1mg dose = 20 units (0.2mL)

Store refrigerated (2–8°C); stable for 30 days after mixing

Common	Rare but Serious
• Mild nausea (20% of users)	• Hyperpigmentation (uneven tan)
• Facial flushing	• New/darkened moles (check skin regularly)
• Slight appetite suppression	• Allergic reaction (rare)